Skip to content

Effects of Two Supervised Training Programs for the Rehabilitation of Ankle Sprains

Effects of Supervised Balance and Proprioceptive Neuromuscular Facilitation Training After Lateral Ligament Sprains of the Ankle

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01853462
Enrollment
22
Registered
2013-05-15
Start date
2014-12-31
Completion date
2016-09-30
Last updated
2018-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Sprains

Brief summary

The purpose of this study was to determine the effects of supervised balance and proprioceptive neuromuscular facilitation (PNF) training for the rehabilitation of ankle sprains

Detailed description

Supervised proprioceptive training has been recommended by recently published guidelines for the rehabilitation of ankle sprains. However, research evidence on the efficacy of this type of training is still weak, mainly owing to the methodological limitations of relevant studies. In addition, there is paucity of evidence concerning the effects of such training for the outcomes of functional performance, pain, ankle range of motion, and contradictory results have been reported for postural control. This study aimed to substantiate the benefits of supervised training for the rehabilitation of ankle sprains, and elucidate the effects of two different proprioceptive protocols on the above-mentioned outcomes.

Interventions

Ten individual PNF sessions, supervised by a physical therapist, with 50-60 min duration per session, within a maximal five-week period

OTHERBalance training

Ten individual balance sessions, supervised by a physical therapist, with 50-60 min duration per session, within a maximal five-week period

Sponsors

Lazaros Lazarou
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Individuals with a symptomatic, conventionally treated, post acute (after 14 days) lateral ankle sprain, Grade I-II

Exclusion criteria

* Individuals with lateral ankle sprains Grade III * Individuals with ankle sprain to the medial ligaments * Individuals with ankle sprain to the interosseous (syndesmotic) ligament * Individuals with concurrent fracture * Individuals with chronic ankle instability * Individuals with history of surgery to the ankles * Individuals with history of lower limb nerve injuries * Individuals with history of further ankle injuries, after the sprain * Individuals with any injuries that hindered training participation

Design outcomes

Primary

MeasureTime frameDescription
Ankle Functional Stability, Via the Single-leg Hop for Distance TestBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)Participants hopped, using the sprained leg, as far forward as possible, and remained in the landing position for 2sec. Three trials were performed, and the mean hopping distance was used for analysis.
Ankle Functional Stability, Via the Single-leg Hops for Time TestBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)Participants hopped, using the sprained leg, as fast as possible, a six-meter distance. Three trials were performed, and the mean hopping time was used for analysis.
Endurance of Ankle Dorsiflexor MusclesBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The rising on heel test was used, and participants rose on the heel of the sprained leg, as many times as possible. Scoring:10 points for \>40 rises, 5 points for 30-39 rises, 0 points for \<30 rises.
Endurance of Ankle Plantar Flexor MusclesBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The rising on toes test was used, and participants rose on the toes of the sprained leg, as many times as possible. Scoring:10 points for \>40 rises, 5 points for 30-39 rises, 0 points for \<30 rises.

Secondary

MeasureTime frameDescription
Pain SensationBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The main component of the Greek version of the short form of McGill Pain Questionnaire (GR-SFMPQ) was used for the assessment of pain sensation of the sprained ankle. This consists of 15 descriptive adjectives for the pain sensation (11 sensory and 4 affective), which are self-rated according to their intensity level on a 4-point rating scale (0 = none, 1 = mild, 2 = moderate, 3 = severe). The total rating score (minimum = 0, maximum = 45) of the main component of the GR-SFMPQ was used for data analysis, with higher values representing a worse pain sensation.
Pain Intensity During the Week Before TestingBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The second component of the Greek version of the short form of McGill Pain Questionnaire, which is a visual analogue scale (VAS), was used for the assessment. The VAS is a horizontal 10-cm line with clearly defined boundaries: 0 cm = 'No pain' and 10.0 cm = 'worst possible pain'. partipants made a mark on the line at the point that better described the average pain intensity for their sprained ankle, during the week before testing. The distance marked from the 'no pain' point was measured in mm and was used for data analysis.
Present PainBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The third component of the Greek version of the short form of McGill Pain Questionnaire, which is a 6-point verbal rating scale, was used for the assessment. Participants noted what word at the time completing the questionnaire would best describe their pain sensation for the sprained ankle (scoring: no pain = 0, mild = 1, discomforting = 2, distressing = 3, horrible = 4, excruciating = 5). The score corresponding to the noted word was used for data analysis, with higher values representing a worse pain sensation.
Ankle Joint Sense for 10° DorsiflexionBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The Biodex isokinetic dynamometer was used for assessment. During testing, participants were blindfolded, in the seated position, with footwear on.The internal goniometer of Biodex recorded the degrees of error for the active repositioning of 10° dorsiflexion (non-weight-bearing) for the sprained ankle, and the mean of three trials was used for analysis.
Ankle Joint Sense for 15° Plantar FlexionBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The Biodex isokinetic dynamometer was used for assessment. During testing, participants were blindfolded, in the seated position, with footwear on.The internal goniometer of Biodex recorded the degrees of error for the active repositioning of 15° plantar flexion (non-weight-bearing) for the sprained ankle, and the mean of three trials was used for analysis.
Ankle Joint Sense for 30° Plantar FlexionBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The Biodex isokinetic dynamometer was used for assessment. During testing, participants were blindfolded, in the seated position, with footwear on.The internal goniometer of Biodex recorded the degrees of error for the active repositioning of 30° plantar flexion (non-weight-bearing) for the sprained ankle, and the mean of three trials was used for analysis.
Peak Torque of Ankle Dorsiflexor Muscles at 30°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the ankle joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.
Peak Torque of Ankle Dorsiflexor Muscles at 120°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the ankle joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.
Peak Torque of Ankle Plantar Flexor Muscles at 30°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the ankle joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.
Peak Torque of Ankle Plantar Flexor Muscles at 120°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the ankle joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.
Peak Torque of Foot Evertor Muscles at 30°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the subtalar joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.
Anterior-posterior Stability IndexBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The Biodex Stability System, which is a dynamic tilting platform, was used for assessment. The anterior-posterior stability index corresponded to the variance of foot platform displacement in the sagittal plane, and it was measured in single-leg stance, for the sprained leg, without footwear. Three 20-sec trials were performed, with open eyes, and the mean score was used for analysis.
Peak Torque of Foot Invertor Muscles at 30°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the subtalar joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.
Peak Torque of Foot Invertor Muscles at 120°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the subtalar joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.
Electromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 30°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the ankle dorsiflexor muscles, at 30°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the anterior tibialis muscle was used as the reference value for normalization.
Electromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 120°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the ankle dorsiflexor muscles, at 120°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the anterior tibialis muscle was used as the reference value for normalization.
Electromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 30°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the ankle plantar flexor muscles, at 30°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the peroneus longus muscle was used as the reference value for normalization.
Electromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 120°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the ankle plantar flexor muscles, at 120°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the peroneus longus muscle was used as the reference value for normalization.
Electromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 30°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the foot evertor muscles, at 30°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the peroneus longus muscle was used as the reference value for normalization.
Electromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 120°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the foot evertor muscles, at 120°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the peroneus longus muscle was used as the reference value for normalization.
Electromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 30°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the foot invertor muscles, at 30°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the anterior tibialis muscle was used as the reference value for normalization.
Electromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 120°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the foot invertor muscles, at 120°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the anterior tibialis muscle was used as the reference value for normalization.
Participants With Recurrent Ankle SprainTwelve months after the completion of training
Peak Torque of Foot Evertor Muscles at 120°/Sec SpeedBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the subtalar joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.
Medial-lateral Stability IndexBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The Biodex Stability System, which is a dynamic tilting platform, was used for assessment. The medial-lateral stability index corresponded to the variance of foot platform displacement in the frontal plane, and it was measured in single-leg stance, for the sprained leg, without footwear. Three 20-sec trials were performed, with open eyes, and the mean score was used for analysis.
Overall Stability IndexBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)The Biodex Stability System, which is a dynamic tilting platform, was used for assessment. The overall stability index corresponded to the variance of foot platform overall displacement, and it was measured in single-leg stance, for the sprained leg, without footwear. Three 20-sec trials were performed, with open eyes, and the mean score was used for analysis.
Ankle Dorsiflexion Range of MotionBaseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)Assessement was performed with a goniometer. Participants actively dorsiflexed the sprained ankle, while being in long sitting, on a physical therapy table. The mean score of three measurements was used for analysis.

Countries

Greece

Participant flow

Participants by arm

ArmCount
Proprioceptive Neuromuscular Facilitation (PNF)
PNF training proprioceptive neuromuscular facilitation exercise program: Ten individual sessions (50-60min per session) of PNF training, supervised by a physical therapist
10
Balance
Balance training balance exercise program: Ten individual sessions (50-60min per session) of balance training, supervised by a physical therapist
10
Total20

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject11

Baseline characteristics

CharacteristicProprioceptive Neuromuscular Facilitation (PNF)BalanceTotal
Age, Continuous21.8 years
STANDARD_DEVIATION 3.8
21.5 years
STANDARD_DEVIATION 1.8
21.7 years
STANDARD_DEVIATION 2.9
Sex: Female, Male
Female
7 Participants7 Participants14 Participants
Sex: Female, Male
Male
3 Participants3 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 110 / 11
other
Total, other adverse events
0 / 110 / 11
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Ankle Functional Stability, Via the Single-leg Hop for Distance Test

Participants hopped, using the sprained leg, as far forward as possible, and remained in the landing position for 2sec. Three trials were performed, and the mean hopping distance was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Functional Stability, Via the Single-leg Hop for Distance TestBaseline65.6 CentimetersStandard Deviation 17
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Functional Stability, Via the Single-leg Hop for Distance TestFollow-up 1100.3 CentimetersStandard Deviation 17
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Functional Stability, Via the Single-leg Hop for Distance TestFollow-up 277.0 CentimetersStandard Deviation 17.6
BalanceAnkle Functional Stability, Via the Single-leg Hop for Distance TestBaseline82.8 CentimetersStandard Deviation 19.5
BalanceAnkle Functional Stability, Via the Single-leg Hop for Distance TestFollow-up 1101.4 CentimetersStandard Deviation 29.8
BalanceAnkle Functional Stability, Via the Single-leg Hop for Distance TestFollow-up 2110.0 CentimetersStandard Deviation 30.5
Primary

Ankle Functional Stability, Via the Single-leg Hops for Time Test

Participants hopped, using the sprained leg, as fast as possible, a six-meter distance. Three trials were performed, and the mean hopping time was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Functional Stability, Via the Single-leg Hops for Time TestBaseline2.9 SecondsStandard Deviation 0.6
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Functional Stability, Via the Single-leg Hops for Time TestFollow-up 12.1 SecondsStandard Deviation 0.2
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Functional Stability, Via the Single-leg Hops for Time TestFollow-up 22.1 SecondsStandard Deviation 0.3
BalanceAnkle Functional Stability, Via the Single-leg Hops for Time TestBaseline3.3 SecondsStandard Deviation 0.4
BalanceAnkle Functional Stability, Via the Single-leg Hops for Time TestFollow-up 12.7 SecondsStandard Deviation 0.4
BalanceAnkle Functional Stability, Via the Single-leg Hops for Time TestFollow-up 22.2 SecondsStandard Deviation 0.4
Primary

Endurance of Ankle Dorsiflexor Muscles

The rising on heel test was used, and participants rose on the heel of the sprained leg, as many times as possible. Scoring:10 points for \>40 rises, 5 points for 30-39 rises, 0 points for \<30 rises.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEDIAN)
Proprioceptive Neuromuscular Facilitation (PNF)Endurance of Ankle Dorsiflexor MusclesBaseline0 points on a scale
Proprioceptive Neuromuscular Facilitation (PNF)Endurance of Ankle Dorsiflexor MusclesFollow-up 110 points on a scale
Proprioceptive Neuromuscular Facilitation (PNF)Endurance of Ankle Dorsiflexor MusclesFollow-up 27.5 points on a scale
BalanceEndurance of Ankle Dorsiflexor MusclesBaseline5 points on a scale
BalanceEndurance of Ankle Dorsiflexor MusclesFollow-up 110 points on a scale
BalanceEndurance of Ankle Dorsiflexor MusclesFollow-up 210 points on a scale
Primary

Endurance of Ankle Plantar Flexor Muscles

The rising on toes test was used, and participants rose on the toes of the sprained leg, as many times as possible. Scoring:10 points for \>40 rises, 5 points for 30-39 rises, 0 points for \<30 rises.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEDIAN)
Proprioceptive Neuromuscular Facilitation (PNF)Endurance of Ankle Plantar Flexor MusclesBaseline0 points on a scale
Proprioceptive Neuromuscular Facilitation (PNF)Endurance of Ankle Plantar Flexor MusclesFollow-up 15 points on a scale
Proprioceptive Neuromuscular Facilitation (PNF)Endurance of Ankle Plantar Flexor MusclesFollow-up 27.5 points on a scale
BalanceEndurance of Ankle Plantar Flexor MusclesFollow-up 17.5 points on a scale
BalanceEndurance of Ankle Plantar Flexor MusclesBaseline0 points on a scale
BalanceEndurance of Ankle Plantar Flexor MusclesFollow-up 27.5 points on a scale
Secondary

Ankle Dorsiflexion Range of Motion

Assessement was performed with a goniometer. Participants actively dorsiflexed the sprained ankle, while being in long sitting, on a physical therapy table. The mean score of three measurements was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Dorsiflexion Range of MotionBaseline7 DegreesStandard Deviation 3
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Dorsiflexion Range of MotionFollow-up 113 DegreesStandard Deviation 3
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Dorsiflexion Range of MotionFollow-up 215 DegreesStandard Deviation 2
BalanceAnkle Dorsiflexion Range of MotionBaseline8 DegreesStandard Deviation 2
BalanceAnkle Dorsiflexion Range of MotionFollow-up 115 DegreesStandard Deviation 2
BalanceAnkle Dorsiflexion Range of MotionFollow-up 215 DegreesStandard Deviation 1
Secondary

Ankle Joint Sense for 10° Dorsiflexion

The Biodex isokinetic dynamometer was used for assessment. During testing, participants were blindfolded, in the seated position, with footwear on.The internal goniometer of Biodex recorded the degrees of error for the active repositioning of 10° dorsiflexion (non-weight-bearing) for the sprained ankle, and the mean of three trials was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Joint Sense for 10° DorsiflexionBaseline4 DegreesStandard Deviation 2
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Joint Sense for 10° DorsiflexionFollow-up 11 DegreesStandard Deviation 1
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Joint Sense for 10° DorsiflexionFollow-up 25 DegreesStandard Deviation 3
BalanceAnkle Joint Sense for 10° DorsiflexionFollow-up 24 DegreesStandard Deviation 2
BalanceAnkle Joint Sense for 10° DorsiflexionBaseline6 DegreesStandard Deviation 4
BalanceAnkle Joint Sense for 10° DorsiflexionFollow-up 13 DegreesStandard Deviation 3
Secondary

Ankle Joint Sense for 15° Plantar Flexion

The Biodex isokinetic dynamometer was used for assessment. During testing, participants were blindfolded, in the seated position, with footwear on.The internal goniometer of Biodex recorded the degrees of error for the active repositioning of 15° plantar flexion (non-weight-bearing) for the sprained ankle, and the mean of three trials was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Joint Sense for 15° Plantar FlexionBaseline10 DegreesStandard Deviation 4
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Joint Sense for 15° Plantar FlexionFollow-up 17 DegreesStandard Deviation 3
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Joint Sense for 15° Plantar FlexionFollow-up 28 DegreesStandard Deviation 3
BalanceAnkle Joint Sense for 15° Plantar FlexionBaseline9 DegreesStandard Deviation 4
BalanceAnkle Joint Sense for 15° Plantar FlexionFollow-up 15 DegreesStandard Deviation 1
BalanceAnkle Joint Sense for 15° Plantar FlexionFollow-up 25 DegreesStandard Deviation 1
Secondary

Ankle Joint Sense for 30° Plantar Flexion

The Biodex isokinetic dynamometer was used for assessment. During testing, participants were blindfolded, in the seated position, with footwear on.The internal goniometer of Biodex recorded the degrees of error for the active repositioning of 30° plantar flexion (non-weight-bearing) for the sprained ankle, and the mean of three trials was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Joint Sense for 30° Plantar FlexionBaseline7 DegreesStandard Deviation 6
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Joint Sense for 30° Plantar FlexionFollow-up 14 DegreesStandard Deviation 2
Proprioceptive Neuromuscular Facilitation (PNF)Ankle Joint Sense for 30° Plantar FlexionFollow-up 25 DegreesStandard Deviation 2
BalanceAnkle Joint Sense for 30° Plantar FlexionBaseline4 DegreesStandard Deviation 3
BalanceAnkle Joint Sense for 30° Plantar FlexionFollow-up 13 DegreesStandard Deviation 1
BalanceAnkle Joint Sense for 30° Plantar FlexionFollow-up 23 DegreesStandard Deviation 2
Secondary

Anterior-posterior Stability Index

The Biodex Stability System, which is a dynamic tilting platform, was used for assessment. The anterior-posterior stability index corresponded to the variance of foot platform displacement in the sagittal plane, and it was measured in single-leg stance, for the sprained leg, without footwear. Three 20-sec trials were performed, with open eyes, and the mean score was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Anterior-posterior Stability IndexBaseline2.6 DegreesStandard Deviation 0.6
Proprioceptive Neuromuscular Facilitation (PNF)Anterior-posterior Stability IndexFollow-up 12.6 DegreesStandard Deviation 0.3
Proprioceptive Neuromuscular Facilitation (PNF)Anterior-posterior Stability IndexFollow-up 22.5 DegreesStandard Deviation 0.4
BalanceAnterior-posterior Stability IndexBaseline3.1 DegreesStandard Deviation 0.6
BalanceAnterior-posterior Stability IndexFollow-up 13.0 DegreesStandard Deviation 0.7
BalanceAnterior-posterior Stability IndexFollow-up 23.1 DegreesStandard Deviation 0.7
Secondary

Electromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 120°/Sec Speed

Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the ankle dorsiflexor muscles, at 120°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the anterior tibialis muscle was used as the reference value for normalization.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 120°/Sec SpeedBaseline0.99 ProportionStandard Deviation 0.13
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 120°/Sec SpeedFollow up 10.98 ProportionStandard Deviation 0.17
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 120°/Sec SpeedFollow up 21.02 ProportionStandard Deviation 0.21
BalanceElectromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 120°/Sec SpeedBaseline0.88 ProportionStandard Deviation 0.23
BalanceElectromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 120°/Sec SpeedFollow up 10.85 ProportionStandard Deviation 0.15
BalanceElectromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 120°/Sec SpeedFollow up 20.83 ProportionStandard Deviation 0.13
Secondary

Electromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 30°/Sec Speed

Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the ankle dorsiflexor muscles, at 30°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the anterior tibialis muscle was used as the reference value for normalization.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 30°/Sec SpeedBaseline1.02 ProportionStandard Deviation 0.25
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 30°/Sec SpeedFollow up 10.90 ProportionStandard Deviation 0.24
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 30°/Sec SpeedFollow up 21.02 ProportionStandard Deviation 0.27
BalanceElectromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 30°/Sec SpeedBaseline0.88 ProportionStandard Deviation 0.1
BalanceElectromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 30°/Sec SpeedFollow up 11.03 ProportionStandard Deviation 0.1
BalanceElectromyographic Activity of Anterior Tibialis Muscle During Ankle Dorsiflexion at 30°/Sec SpeedFollow up 20.92 ProportionStandard Deviation 0.13
Secondary

Electromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 120°/Sec Speed

Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the ankle plantar flexor muscles, at 120°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the peroneus longus muscle was used as the reference value for normalization.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 120°/Sec SpeedBaseline0.82 ProportionStandard Deviation 0.28
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 120°/Sec SpeedFollow up 10.68 ProportionStandard Deviation 0.21
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 120°/Sec SpeedFollow up 20.71 ProportionStandard Deviation 0.16
BalanceElectromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 120°/Sec SpeedBaseline0.61 ProportionStandard Deviation 0.15
BalanceElectromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 120°/Sec SpeedFollow up 10.71 ProportionStandard Deviation 0.1
BalanceElectromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 120°/Sec SpeedFollow up 20.83 ProportionStandard Deviation 0.12
Secondary

Electromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 30°/Sec Speed

Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the ankle plantar flexor muscles, at 30°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the peroneus longus muscle was used as the reference value for normalization.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 30°/Sec SpeedBaseline0.78 ProportionStandard Deviation 0.21
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 30°/Sec SpeedFollow up 10.60 ProportionStandard Deviation 0.16
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 30°/Sec SpeedFollow up 20.61 ProportionStandard Deviation 0.15
BalanceElectromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 30°/Sec SpeedBaseline0.64 ProportionStandard Deviation 0.09
BalanceElectromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 30°/Sec SpeedFollow up 10.76 ProportionStandard Deviation 0.12
BalanceElectromyographic Activity of Peroneus Longus Muscle During Ankle Plantar Flexion at 30°/Sec SpeedFollow up 20.68 ProportionStandard Deviation 0.14
Secondary

Electromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 120°/Sec Speed

Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the foot evertor muscles, at 120°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the peroneus longus muscle was used as the reference value for normalization.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 120°/Sec SpeedBaseline0.95 ProportionStandard Deviation 0.34
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 120°/Sec SpeedFollow up 10.67 ProportionStandard Deviation 0.26
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 120°/Sec SpeedFollow up 20.87 ProportionStandard Deviation 0.43
BalanceElectromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 120°/Sec SpeedBaseline0.75 ProportionStandard Deviation 0.15
BalanceElectromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 120°/Sec SpeedFollow up 10.70 ProportionStandard Deviation 0.15
BalanceElectromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 120°/Sec SpeedFollow up 20.74 ProportionStandard Deviation 0.16
Secondary

Electromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 30°/Sec Speed

Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the foot evertor muscles, at 30°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the peroneus longus muscle was used as the reference value for normalization.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 30°/Sec SpeedBaseline0.89 ProportionStandard Deviation 0.24
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 30°/Sec SpeedFollow up 10.78 ProportionStandard Deviation 0.22
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 30°/Sec SpeedFollow up 20.92 ProportionStandard Deviation 0.17
BalanceElectromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 30°/Sec SpeedBaseline0.70 ProportionStandard Deviation 0.22
BalanceElectromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 30°/Sec SpeedFollow up 10.68 ProportionStandard Deviation 0.12
BalanceElectromyographic Activity of Peroneus Longus Muscle During Foot Eversion at 30°/Sec SpeedFollow up 20.63 ProportionStandard Deviation 0.16
Secondary

Electromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 120°/Sec Speed

Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the foot invertor muscles, at 120°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the anterior tibialis muscle was used as the reference value for normalization.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 120°/Sec SpeedBaseline0.43 ProportionStandard Deviation 0.12
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 120°/Sec SpeedFollow up 10.45 ProportionStandard Deviation 0.16
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 120°/Sec SpeedFollow up 20.38 ProportionStandard Deviation 0.14
BalanceElectromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 120°/Sec SpeedBaseline0.44 ProportionStandard Deviation 0.15
BalanceElectromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 120°/Sec SpeedFollow up 10.36 ProportionStandard Deviation 0.14
BalanceElectromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 120°/Sec SpeedFollow up 20.32 ProportionStandard Deviation 0.17
Secondary

Electromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 30°/Sec Speed

Two surface electrodes and a ground electrode were used for assessment. Measurements were taken for the sprained leg, during isokinetic testing of the foot invertor muscles, at 30°/sec speed, with the Biodex dynamometer. Normalized values of the electromyographic (EMG) signals were used for analysis, and EMG activity during maximal voluntary isometric contraction of the anterior tibialis muscle was used as the reference value for normalization.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 30°/Sec SpeedBaseline0.40 ProportionStandard Deviation 0.11
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 30°/Sec SpeedFollow up 10.32 ProportionStandard Deviation 0.13
Proprioceptive Neuromuscular Facilitation (PNF)Electromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 30°/Sec SpeedFollow up 20.54 ProportionStandard Deviation 0.16
BalanceElectromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 30°/Sec SpeedBaseline0.39 ProportionStandard Deviation 0.1
BalanceElectromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 30°/Sec SpeedFollow up 10.40 ProportionStandard Deviation 0.18
BalanceElectromyographic Activity of Tibialis Anterior Muscle During Foot Inversion at 30°/Sec SpeedFollow up 20.31 ProportionStandard Deviation 0.15
Secondary

Medial-lateral Stability Index

The Biodex Stability System, which is a dynamic tilting platform, was used for assessment. The medial-lateral stability index corresponded to the variance of foot platform displacement in the frontal plane, and it was measured in single-leg stance, for the sprained leg, without footwear. Three 20-sec trials were performed, with open eyes, and the mean score was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Medial-lateral Stability IndexBaseline1.9 DegreesStandard Deviation 0.5
Proprioceptive Neuromuscular Facilitation (PNF)Medial-lateral Stability IndexFollow-up 11.7 DegreesStandard Deviation 0.5
Proprioceptive Neuromuscular Facilitation (PNF)Medial-lateral Stability IndexFollow-up 21.6 DegreesStandard Deviation 0.4
BalanceMedial-lateral Stability IndexBaseline1.9 DegreesStandard Deviation 0.4
BalanceMedial-lateral Stability IndexFollow-up 12.0 DegreesStandard Deviation 0.5
BalanceMedial-lateral Stability IndexFollow-up 21.5 DegreesStandard Deviation 0.3
Secondary

Overall Stability Index

The Biodex Stability System, which is a dynamic tilting platform, was used for assessment. The overall stability index corresponded to the variance of foot platform overall displacement, and it was measured in single-leg stance, for the sprained leg, without footwear. Three 20-sec trials were performed, with open eyes, and the mean score was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Overall Stability IndexBaseline3.1 DegreesStandard Deviation 0.7
Proprioceptive Neuromuscular Facilitation (PNF)Overall Stability IndexFollow-up 13.0 DegreesStandard Deviation 0.6
Proprioceptive Neuromuscular Facilitation (PNF)Overall Stability IndexFollow-up 22.9 DegreesStandard Deviation 0.6
BalanceOverall Stability IndexBaseline3.6 DegreesStandard Deviation 0.8
BalanceOverall Stability IndexFollow-up 13.4 DegreesStandard Deviation 0.5
BalanceOverall Stability IndexFollow-up 23.4 DegreesStandard Deviation 0.6
Secondary

Pain Intensity During the Week Before Testing

The second component of the Greek version of the short form of McGill Pain Questionnaire, which is a visual analogue scale (VAS), was used for the assessment. The VAS is a horizontal 10-cm line with clearly defined boundaries: 0 cm = 'No pain' and 10.0 cm = 'worst possible pain'. partipants made a mark on the line at the point that better described the average pain intensity for their sprained ankle, during the week before testing. The distance marked from the 'no pain' point was measured in mm and was used for data analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Pain Intensity During the Week Before TestingBaseline2.0 Points on a scaleStandard Deviation 1.6
Proprioceptive Neuromuscular Facilitation (PNF)Pain Intensity During the Week Before TestingFollow-up 10.4 Points on a scaleStandard Deviation 0.4
Proprioceptive Neuromuscular Facilitation (PNF)Pain Intensity During the Week Before TestingFollow-up 21.3 Points on a scaleStandard Deviation 1
BalancePain Intensity During the Week Before TestingBaseline2.8 Points on a scaleStandard Deviation 2.1
BalancePain Intensity During the Week Before TestingFollow-up 11.1 Points on a scaleStandard Deviation 1.3
BalancePain Intensity During the Week Before TestingFollow-up 20.5 Points on a scaleStandard Deviation 0.7
Secondary

Pain Sensation

The main component of the Greek version of the short form of McGill Pain Questionnaire (GR-SFMPQ) was used for the assessment of pain sensation of the sprained ankle. This consists of 15 descriptive adjectives for the pain sensation (11 sensory and 4 affective), which are self-rated according to their intensity level on a 4-point rating scale (0 = none, 1 = mild, 2 = moderate, 3 = severe). The total rating score (minimum = 0, maximum = 45) of the main component of the GR-SFMPQ was used for data analysis, with higher values representing a worse pain sensation.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEDIAN)
Proprioceptive Neuromuscular Facilitation (PNF)Pain SensationBaseline7 Total score of scales
Proprioceptive Neuromuscular Facilitation (PNF)Pain SensationFollow-up 10 Total score of scales
Proprioceptive Neuromuscular Facilitation (PNF)Pain SensationFollow-up 23.5 Total score of scales
BalancePain SensationBaseline6 Total score of scales
BalancePain SensationFollow-up 10 Total score of scales
BalancePain SensationFollow-up 20.5 Total score of scales
Secondary

Participants With Recurrent Ankle Sprain

Time frame: Twelve months after the completion of training

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Proprioceptive Neuromuscular Facilitation (PNF)Participants With Recurrent Ankle Sprain2 Participants
BalanceParticipants With Recurrent Ankle Sprain0 Participants
Secondary

Peak Torque of Ankle Dorsiflexor Muscles at 120°/Sec Speed

The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the ankle joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Ankle Dorsiflexor Muscles at 120°/Sec SpeedBaseline20.3 Newton metresStandard Deviation 4.2
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Ankle Dorsiflexor Muscles at 120°/Sec SpeedFollow-up 119.0 Newton metresStandard Deviation 5.4
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Ankle Dorsiflexor Muscles at 120°/Sec SpeedFollow-up 219.4 Newton metresStandard Deviation 4.1
BalancePeak Torque of Ankle Dorsiflexor Muscles at 120°/Sec SpeedBaseline22.7 Newton metresStandard Deviation 5.9
BalancePeak Torque of Ankle Dorsiflexor Muscles at 120°/Sec SpeedFollow-up 121.4 Newton metresStandard Deviation 5.5
BalancePeak Torque of Ankle Dorsiflexor Muscles at 120°/Sec SpeedFollow-up 222.1 Newton metresStandard Deviation 5.5
Secondary

Peak Torque of Ankle Dorsiflexor Muscles at 30°/Sec Speed

The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the ankle joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Ankle Dorsiflexor Muscles at 30°/Sec SpeedBaseline35.8 Newton metresStandard Deviation 8.2
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Ankle Dorsiflexor Muscles at 30°/Sec SpeedFollow-up 130.7 Newton metresStandard Deviation 7.3
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Ankle Dorsiflexor Muscles at 30°/Sec SpeedFollow-up 230.8 Newton metresStandard Deviation 5.8
BalancePeak Torque of Ankle Dorsiflexor Muscles at 30°/Sec SpeedBaseline31.7 Newton metresStandard Deviation 6.8
BalancePeak Torque of Ankle Dorsiflexor Muscles at 30°/Sec SpeedFollow-up 132.3 Newton metresStandard Deviation 8.6
BalancePeak Torque of Ankle Dorsiflexor Muscles at 30°/Sec SpeedFollow-up 230.3 Newton metresStandard Deviation 7.3
Secondary

Peak Torque of Ankle Plantar Flexor Muscles at 120°/Sec Speed

The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the ankle joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Ankle Plantar Flexor Muscles at 120°/Sec SpeedBaseline17.4 Newton metresStandard Deviation 4.6
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Ankle Plantar Flexor Muscles at 120°/Sec SpeedFollow up 125.0 Newton metresStandard Deviation 13.4
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Ankle Plantar Flexor Muscles at 120°/Sec SpeedFollow up 225.0 Newton metresStandard Deviation 8.6
BalancePeak Torque of Ankle Plantar Flexor Muscles at 120°/Sec SpeedBaseline26.0 Newton metresStandard Deviation 15.5
BalancePeak Torque of Ankle Plantar Flexor Muscles at 120°/Sec SpeedFollow up 140.2 Newton metresStandard Deviation 12.1
BalancePeak Torque of Ankle Plantar Flexor Muscles at 120°/Sec SpeedFollow up 238.1 Newton metresStandard Deviation 12.4
Secondary

Peak Torque of Ankle Plantar Flexor Muscles at 30°/Sec Speed

The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the ankle joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Ankle Plantar Flexor Muscles at 30°/Sec SpeedBaseline31.5 Newton metresStandard Deviation 13.8
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Ankle Plantar Flexor Muscles at 30°/Sec SpeedFollow-up 146.1 Newton metresStandard Deviation 11.3
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Ankle Plantar Flexor Muscles at 30°/Sec SpeedFollow-up 253.5 Newton metresStandard Deviation 14.7
BalancePeak Torque of Ankle Plantar Flexor Muscles at 30°/Sec SpeedBaseline47.8 Newton metresStandard Deviation 23.6
BalancePeak Torque of Ankle Plantar Flexor Muscles at 30°/Sec SpeedFollow-up 180.6 Newton metresStandard Deviation 31.4
BalancePeak Torque of Ankle Plantar Flexor Muscles at 30°/Sec SpeedFollow-up 265.5 Newton metresStandard Deviation 25.5
Secondary

Peak Torque of Foot Evertor Muscles at 120°/Sec Speed

The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the subtalar joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Foot Evertor Muscles at 120°/Sec SpeedBaseline8.0 Newton metresStandard Deviation 1.4
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Foot Evertor Muscles at 120°/Sec SpeedFollow up 110.5 Newton metresStandard Deviation 2.3
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Foot Evertor Muscles at 120°/Sec SpeedFollow up 210.5 Newton metresStandard Deviation 3.1
BalancePeak Torque of Foot Evertor Muscles at 120°/Sec SpeedBaseline9.1 Newton metresStandard Deviation 1.5
BalancePeak Torque of Foot Evertor Muscles at 120°/Sec SpeedFollow up 18.6 Newton metresStandard Deviation 2.2
BalancePeak Torque of Foot Evertor Muscles at 120°/Sec SpeedFollow up 213.0 Newton metresStandard Deviation 3
Secondary

Peak Torque of Foot Evertor Muscles at 30°/Sec Speed

The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the subtalar joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Foot Evertor Muscles at 30°/Sec SpeedBaseline11.9 Newton metresStandard Deviation 1.8
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Foot Evertor Muscles at 30°/Sec SpeedFollow up 113.0 Newton metresStandard Deviation 3.8
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Foot Evertor Muscles at 30°/Sec SpeedFollow up 213.9 Newton metresStandard Deviation 4
BalancePeak Torque of Foot Evertor Muscles at 30°/Sec SpeedBaseline13.6 Newton metresStandard Deviation 2.5
BalancePeak Torque of Foot Evertor Muscles at 30°/Sec SpeedFollow up 114.5 Newton metresStandard Deviation 2
BalancePeak Torque of Foot Evertor Muscles at 30°/Sec SpeedFollow up 218.8 Newton metresStandard Deviation 2.3
Secondary

Peak Torque of Foot Invertor Muscles at 120°/Sec Speed

The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the subtalar joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Foot Invertor Muscles at 120°/Sec SpeedBaseline6.7 Newton metresStandard Deviation 2.3
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Foot Invertor Muscles at 120°/Sec SpeedFollow up 19.5 Newton metresStandard Deviation 3.2
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Foot Invertor Muscles at 120°/Sec SpeedFollow up 221.6 Newton metresStandard Deviation 5.7
BalancePeak Torque of Foot Invertor Muscles at 120°/Sec SpeedBaseline9.3 Newton metresStandard Deviation 3.5
BalancePeak Torque of Foot Invertor Muscles at 120°/Sec SpeedFollow up 112.0 Newton metresStandard Deviation 3.7
BalancePeak Torque of Foot Invertor Muscles at 120°/Sec SpeedFollow up 227.7 Newton metresStandard Deviation 8.9
Secondary

Peak Torque of Foot Invertor Muscles at 30°/Sec Speed

The Biodex isokinetic dynamometer was used for assessment. During isokinetic testing of the subtalar joint, participants were in the seated position, with footwear on. Measurements were taken for the sprained leg, and the mean of five maximal trials was used for analysis.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEAN)Dispersion
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Foot Invertor Muscles at 30°/Sec SpeedBaseline10.1 Newton metresStandard Deviation 3.2
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Foot Invertor Muscles at 30°/Sec SpeedFollow up 112.6 Newton metresStandard Deviation 5.6
Proprioceptive Neuromuscular Facilitation (PNF)Peak Torque of Foot Invertor Muscles at 30°/Sec SpeedFollow up 226.2 Newton metresStandard Deviation 6.5
BalancePeak Torque of Foot Invertor Muscles at 30°/Sec SpeedFollow up 229.6 Newton metresStandard Deviation 9.9
BalancePeak Torque of Foot Invertor Muscles at 30°/Sec SpeedBaseline12.2 Newton metresStandard Deviation 3.8
BalancePeak Torque of Foot Invertor Muscles at 30°/Sec SpeedFollow up 118.6 Newton metresStandard Deviation 3.7
Secondary

Present Pain

The third component of the Greek version of the short form of McGill Pain Questionnaire, which is a 6-point verbal rating scale, was used for the assessment. Participants noted what word at the time completing the questionnaire would best describe their pain sensation for the sprained ankle (scoring: no pain = 0, mild = 1, discomforting = 2, distressing = 3, horrible = 4, excruciating = 5). The score corresponding to the noted word was used for data analysis, with higher values representing a worse pain sensation.

Time frame: Baseline, after the completion of training (follow-up 1), and eight weeks after the completion of training (follow-up 2)

ArmMeasureGroupValue (MEDIAN)
Proprioceptive Neuromuscular Facilitation (PNF)Present PainBaseline1 Points on a scale
Proprioceptive Neuromuscular Facilitation (PNF)Present PainFollow-up 10 Points on a scale
Proprioceptive Neuromuscular Facilitation (PNF)Present PainFollow-up 21 Points on a scale
BalancePresent PainBaseline1 Points on a scale
BalancePresent PainFollow-up 10 Points on a scale
BalancePresent PainFollow-up 20 Points on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026